Australian Clinical Labs Limited Stock: price and insider trades · Australia

Australian Clinical Labs Limited, classified in the Health Care sector, is a listed company based in Australia. Its insiders report their share dealings to ASX. From 18 October 2025 to 18 October 2026, the disclosure feed for Australian Clinical Labs Limited logged 20 filings by 9 insiders.

The flow runs one way only: 1 insider bought (1 purchase totalling €31k) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive. The largest single trade was a purchase of €31k by Sarah Butler, published on 14 September 2026, equal to 0.0097% of the market capitalisation.

For context, the typical company on the same exchange (median of 2,532 companies) published 3 filings over the same period, against 20 filings here. Our records for Australian Clinical Labs Limited go back to 2026, with 1 purchase and no sales on the open market in total.

The last insider purchase was made public on 14 September 2026, 33 days ago. The median gap between a trade and its publication by ASX is 2 days. That lag is the time during which only the insider knows about the trade.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.